VERVE THERAPEUTICS INC. - COMMON STOCK
7,4100
30-января-25 15:45:00
15 мин. задержка
Акции
-0,2900
-3,77%
Сегодняшний диапазон
7,3850 - 7,9600
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Verve Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference
29 янв 2025 06:00:00 Источник Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Pipeline Progress and Anticipated 2025 Milestones
13 янв 2025 06:00:00 Источник Nasdaq GlobeNewswire
-
Verve Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
08 янв 2025 06:00:00 Источник Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03 янв 2025 15:05:00 Источник Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
29 ноя 2024 15:05:00 Источник Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial Results
05 ноя 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
01 ноя 2024 15:26:49 Источник Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
02 окт 2024 15:05:00 Источник Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03 сен 2024 15:05:00 Источник Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Pipeline Progress and Reports Second Quarter 2024 Financial Results
08 авг 2024 06:00:01 Источник Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
02 авг 2024 15:05:00 Источник Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
01 июл 2024 15:05:00 Источник Nasdaq GlobeNewswire
-
28 июн 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
31 май 2024 15:01:00 Источник Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Leadership Update
31 май 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
Verve Therapeutics to Participate in Upcoming Investor Conferences
30 май 2024 15:01:00 Источник Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results
08 май 2024 06:00:01 Источник Nasdaq GlobeNewswire
-
07 май 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03 май 2024 15:01:00 Источник Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Updates on its PCSK9 Program
02 апр 2024 06:00:00 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >